company

BAGN APOTEK AS

2930 BAGN

Return on Equity
57,71 %
Current Ratio
1,46
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue16 903 000
Net Income835 000
Total Assets4 554 000
Total Equity1 447 000
Income (NOK)2022
Revenue16 903 000
Expenditure15 857 000
Operating Profit1 046 000
Financial Income22 000
Financial Costs0
Financial Balance22 000
Earnings Before Tax1 068 000
Tax233 000
Net Income835 000
Balance (NOK)2022
Total Fixed Assets22 000
Total Current Assets4 532 000
Total Assets4 554 000
Total Retained Equity1 346 000
Total Equity1 447 000
Total Long-Term Debt0
Total Current Debt3 107 000
Total Equity and Debt4 554 000
Cash flow (NOK)2022
Sales Income16 902 000
Other Income0
Revenue16 903 000
Cost of Goods Sold12 231 000
Salary Costs2 906 000
Depreciation4 000
Impairment0
Expenditure15 857 000
Operating Profit1 046 000
Financial Income22 000
Financial Costs0
Financial Balance22 000
Dividends600 000
Net Income835 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures22 000
Total Tangible Assets22 000
Total Fiancial Fixed Assets0
Total Fixed Assets22 000
Stock802 000
Total Investments0
Cash, Bank3 224 000
Total Current Assets4 532 000
Total Assets4 554 000
Total Equity1 447 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 611 000
Unpaid Taxes309 000
Dividends600 000
Other Current Debt354 000
Total Current Debt3 107 000
Total Equity and Debt4 554 000
Financial indicators2022
Return on Equity57,71 %
Debt-to-Equity Ratio0
Operating Profit Margin6,19 %
Current Ratio1,46
Quick Ratio1,97
Equity Ratio0,32
Gross Profit Margin27,64 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English